Developing vaccines based on cutting-edge Toll-Like Receptor (TLR) biology.

Partnership

Transforming the treatment of life-threatening diseases requires a science-driven approach, a dynamic team, and constant innovation. If you are of the same mindset and would like to collaborate with Dynavax, contact our business development department.

Contact
bd@dynavax.com